Scientists test 'Supercharged' immune cells against deadly viruses in vulnerable patients
NCT ID NCT05101213
Summary
This early-stage study is testing whether specially modified immune cells can safely help control serious viral infections in cancer patients with weakened immune systems. Researchers are collecting a patient's own T-cells, genetically engineering them to better target specific viruses like CMV, adenovirus, or COVID-19, and then infusing them back into the patient. The main goals are to see if this process is feasible, safe, and shows early signs of helping fight these infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.